Booming Inseego Is At The Right Time And Place With The Right Products
The pandemic is leading to a structural shift towards digital just when Inseego was emerging with the right products. Demand for its 4G and 5G gear is already booming, and […]
The pandemic is leading to a structural shift towards digital just when Inseego was emerging with the right products. Demand for its 4G and 5G gear is already booming, and […]
The company, rather than facing headwinds from the Covid-19 pandemic, is benefiting from moderate pandemic-induced tailwinds, like cheaper ad rates and accelerated digitalization of the insurance industry. With revenue growing […]
The company has faced headwinds for a couple of years that are prolonged due to the COVID-19 pandemic impact. But underneath, there are still secular tailwinds blazing with ever more […]
The company offers a simple way for companies to digitalize their processes. It has used the pandemic to showcase the speed and ease of building essential processes and it should […]
The shares of Kopin are off from the lows on prospects of ramping up military revenue, increased yield and cost cutting. The company has a strong technology position, in particular […]
The company is rapidly filling the void left by competitors in the subscription pain management device market. It is hiring sales representatives left, right and center, but it is still […]
EDAP, developer of promising medical devices for HIFU and ESWL treatments, has been buffeted by hospitals concentrating on treating Covid-19 patients. However, this looks like postponement to us, with little […]
The company has a fairly unique value proposition for business and is faced with a significant greenfield prospect to conquer. It also has cash to continue investing for almost a […]
Milestone Scientific has a platform technology for the safe delivery of injections, with one application already commercialized and another one (the CompuFlo) close. The health and cost benefits of the […]
Milestone Scientific has a platform technology for the safe delivery of injections, with one application already commercialized and another one (the CompuFlo) close. The health and cost benefits of the […]